贸易债权人 更改
AstraZeneca USD 25.28B 252M 2025-12
Bayer EUR 7.08B 700M 2025-12
Essilor EUR 2.88B 363M 2025-12
Fresenius EUR 1.08B 65M 2025-09
Fresenius Medical Care EUR 835.55M 109.7M 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
GRIFOLS EUR 841M 37.68M 2025-12
Lonza CHF 471M 3M 2024-12
Merck EUR 2.11B 182M 2025-12
Novartis USD 4.46B 99M 2025-12
Philips EUR 1.93B 214M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.93B 927M 2025-12
Smith & Nephew USD 1.19B 73M 2025-12
Sonova Holding CHF 269M 90.8M 2025-06
UCB EUR 4.04B 755M 2025-12